A peptide vaccine targeting the CMV antigen pp65 in children and young adults with recurrent high-grade glioma and medulloblastoma: a phase 1 trial. - Thompson EM; Ashley DM; Ayasoufi K; Norberg P; Archer G; Buckley ED; Herndon JE 2nd; Walter A; Archambault B; Flahiff C; Jaggers D; Gorski L; et al. (Nature cancer, 2025)